Nxera Pharma announced the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region. Mr. Branch will join Nxera?s global Business Development team that is led by Dr. Marcus Messenger. He will be based in Nxera?s Tokyo office and will oversee Japan and regional disease area strategy, search and evaluation, and transaction activities.

Previously a Partner and senior member of the global life sciences practice at L.E.K. Consulting, a global strategy consulting firm, and co-head and representative director of L.E.K.?s Japan office, Mr. Branch brings extensive industry experience from directing strategic consulting projects for L.E.K.'s biopharma, medtech, healthcare and private equity clients. He has advised many executive teams across hundreds of engagements in Japan, APAC and the US on a range of business-critical issues, including growth strategy, business development and M&A, commercial strategy and operations, pricing and market access, and organizational design. Mr. Branch holds an MBA from INSEAD (Fontainebleau, France) and a Masters of Public Health (MPH) from Columbia University, Mailman School of Public Health (New York, USA).

He also holds degrees from the University of Nottingham (Nottingham, UK) and SOAS, University of London (London, UK).